Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Transforaminal steroid injection for lumbar radicular pain proves superior to placebo

30.07.2010
54 percent of patients achieve pain relief after 1 month of treatment

A recent study from Australian researchers determined that transforaminal injection of steroids was a viable alternative to surgery for lumbar radicular pain due to disc herniation.

Full details of the study appear in the August issue of Pain Medicine, a journal published by Wiley-Blackwell on behalf of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists, and the International Spine Intervention Society.

Lumbar radicular pain (sciatica) is most commonly caused by lumbar disc herniation and inflammation of the affected nerve roots. Injections of steroids by various routes are used as an alternative to surgery to reduce the inflammation and relieve the pain. Epidural steroid injection, by either the interlaminar or caudal route, is the most widely used steroid treatment for pain relief. However, studies indicate that interlaminar injections are no more effective than normal saline injections into an interspinous ligament, while caudal epidural injections of steroids have failed to prove superior to local anaesthetic alone.

Transforaminal injection—the injection of steroids directly and accurately onto the affected spinal nerve under radiologic guidance—has proved more effective than interlaminar injection of steroids with respect to pain relief and improvement of disability. However, controlled studies of this method of administration produce conflicting results.

The present study examined whether the transforaminal route of injection or the agent injected is the critical element in determining successful pain relief. Study participants were randomized into one of five groups: Transforaminal injection of steroids (TFST) to test its effectiveness; transforaminal injection of normal saline (TFNS) to test for an irrigation effect; transforaminal injection of local anesthetic (TFLA) to test the effect of a local anesthetic; intramuscular injection of steroids (IMST) to test for a systemic effect; or intramuscular injection of normal saline (IMNS) to test for non-specific (placebo) effects.

A total of 150 patients were enrolled in the study. The inclusion criteria were adult patients, capable of providing consent and capable of complying with the outcome instruments used, with pain radiating into the lower limb of a lancinating, burning, stabbing, or electric quality, limitation of straight-leg-raise to less than 30 degrees, and demonstration of a disc herniation by CT or MRI at a segmental level consistent with the clinical features. Pain of the appropriate quality was the primary indication for treatment. Neurological signs of radiculopathy were not required, but served to consolidate the diagnosis when they were present. All patients were classified as eligible for surgery, meaning that surgery would be the next intervention if injections did not relieve the pain.

Exclusion criteria were foraminal stenosis, severe motor deficit, a history of substance abuse, previous surgery at the affected segmental level, or conditions that rendered an injection unsafe, such as pregnancy, recent infection, or spinal deformity. Patients were not excluded on the basis of duration of pain.

After randomization, the five treatment-groups showed no statistically significant differences in demographic features such as age, gender balance, segmental levels treated, or the proportion of acute or chronic cases.

A standard volume and dose were used for each patient for each type of injection. Patients allocated for TFST received 0.75ml of 0.5% bupivacaine followed by 1.75ml of triamcinalone in a concentration of 40mg/ml. The TFLA group received 2 ml of 0.5% bupivacaine. The TFNS group received 2 ml of the saline agent. Patients in the IMST received 1.75 ml of triamcinolone (40mg/ml). Patients allocated for IMNS received a volume of 2 ml.

The primary outcome measure was the proportion of patients who achieved complete relief of pain or at least 50% relief, at one month after treatment. Secondary outcome measures were function, disability, patient-specified functional outcomes, and use of other health care, and duration of relief beyond one month.

A significantly greater proportion of patients treated with transforaminal injection of steroid (54%) achieved relief of pain than did patients treated with transforaminal injection of local anaesthetic (7%) or transforaminal injection of saline (19%), intramuscular steroids (21%) or intramuscular saline (13%). Relief of pain was corroborated by clinically significant improvements in function and disability, and reductions in use of other health care. Outcomes were equivalent for patients with acute or chronic radicular pain. Twenty-five percent maintained relief beyond 12 months.

Study leader Dr. Bogduk concludes, "In essence, transforaminal injection of steroids is a viable alternative to surgery for lumbar radicular pain due to disc herniation. Its immediate yield is modest, but substantial, and is not simply a placebo effect. For long-term efficacy, proof beyond reasonable doubt would require prohibitively large studies."

Editorial author Dr. Ray Baker concurs. "The study results are particularly impressive given the stringent study design." Dr. Baker also praises the team's method of analysis, the number needed to treat (NNT) measure of treatment effect, stating, "From Bogduk's analysis, one can easily grasp that every third patient will be significantly improved beyond what an intramuscular injection of steroid or a transforaminal injection of normal saline can offer. More to the point, one can observe that one in four patients will retain significant benefit with transforaminal injection of steroids at 12 months, while avoiding the cost of surgery. In the end, this landmark study has vindicated transforaminal steroid injection for lumbar radicular pain as superior to placebo. Further studies are now needed."

Article: "The Efficacy of Transforaminal Injection of Steroids for the Treatment of Lumbar Radicular Pain." Ali Ghahreman, Richard Ferch and Nikolai Bogduk. Pain Medicine; Published Online: July 30, 2010 (DOI: 10.1111/j.1526-4637.2010.00908.x); Print Issue Date: August 2010.

Editorial: "Demystifying Lumbar Transforaminal Epidural Steroids: A Seminal Efficacy Study of a Specific Spinal Injection." Ray Baker. Pain Medicine; Published Online: July 30, 2010 (DOI: 10.1111/j.1526-4637.2010.00920.x); Print Issue Date: August 2010.

This study is published in Pain Medicine. Media wishing to receive a PDF of this article may contact healthnews@wiley.com

Pain Medicine is a multi-disciplinary journal dedicated to the pain clinician, teacher and researcher. It is the Official Journal of the American Academy of Pain Medicine, the International Spine Intervention Society, and of the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists. The journal is devoted to the advancement of pain management, education and research.

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, Inc., with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com.

Dawn Peters | EurekAlert!
Further information:
http://www.wiley.com

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>